CXCL5 and hepatocellular carcinoma: CXCL5 expression was also stronger in HCC cell lines with high metastatic potential than that in their less aggressive counterparts, due to its ability to strongly activate the ERK1/2 and PI3K/AKT signaling pathways in tumor cells.284, 285